185 related articles for article (PubMed ID: 15339304)
1. Calculation of sample size in survival trials: the impact of informative noncompliance.
Jiang Q; Snapinn S; Iglewicz B
Biometrics; 2004 Sep; 60(3):800-6. PubMed ID: 15339304
[TBL] [Abstract][Full Text] [Related]
2. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event.
Li B; Grambsch P
Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209
[TBL] [Abstract][Full Text] [Related]
3. The choice of sample size: a mixed Bayesian / frequentist approach.
Pezeshk H; Nematollahi N; Maroufy V; Gittins J
Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
[TBL] [Abstract][Full Text] [Related]
4. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
Lui KJ; Chang KC
Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
[TBL] [Abstract][Full Text] [Related]
5. A general approach for sample size and statistical power calculations assessing of interventions using a mixture model in the presence of detection limits.
Nie L; Chu H; Cole SR
Contemp Clin Trials; 2006 Oct; 27(5):483-91. PubMed ID: 16769254
[TBL] [Abstract][Full Text] [Related]
6. Sample size calculation for the weighted rank statistics with paired survival data.
Jung SH
Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
[TBL] [Abstract][Full Text] [Related]
7. A behavioral Bayes method to determine the sample size of a clinical trial considering efficacy and safety.
Kikuchi T; Gittins J
Stat Med; 2009 Aug; 28(18):2293-306. PubMed ID: 19536745
[TBL] [Abstract][Full Text] [Related]
8. Sample-size calculations for trials that inform individual treatment decisions: a 'true-choice' approach.
Girling AJ; Lilford RJ; Braunholtz DA; Gillett WR
Clin Trials; 2007; 4(1):15-24. PubMed ID: 17327242
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification.
Lachin JM; Foulkes MA
Biometrics; 1986 Sep; 42(3):507-19. PubMed ID: 3567285
[TBL] [Abstract][Full Text] [Related]
10. Flexible two-stage design with sample size reassessment for survival trials.
Desseaux K; Porcher R
Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
[TBL] [Abstract][Full Text] [Related]
11. Sample size determination for testing equality in a cluster randomized trial with noncompliance.
Lui KJ; Chang KC
J Biopharm Stat; 2011 Jan; 21(1):1-17. PubMed ID: 21191850
[TBL] [Abstract][Full Text] [Related]
12. Sample size for two-stage studies with maintenance therapy.
Feng W; Wahed AS
Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
[TBL] [Abstract][Full Text] [Related]
13. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
Cheng Y; Shen Y
Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
[TBL] [Abstract][Full Text] [Related]
14. A Bayesian approach on sample size calculation for comparing means.
Wang H; Chow SC; Chen M
J Biopharm Stat; 2005; 15(5):799-807. PubMed ID: 16078386
[TBL] [Abstract][Full Text] [Related]
15. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.
Brutti P; De Santis F; Gubbiotti S
Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415
[TBL] [Abstract][Full Text] [Related]
16. The reassessment of trial perspectives from interim data--a critical view.
Bauer P; Koenig F
Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
[TBL] [Abstract][Full Text] [Related]
17. Sample size determination for clinical trials in patients with nonlinear disease progression.
Yan X; Su X
J Biopharm Stat; 2006; 16(1):91-105. PubMed ID: 16440839
[TBL] [Abstract][Full Text] [Related]
18. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.
Leon AC
J Clin Psychiatry; 2004 Nov; 65(11):1511-4. PubMed ID: 15554764
[TBL] [Abstract][Full Text] [Related]
19. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
Lui KJ; Chang KC
Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
[TBL] [Abstract][Full Text] [Related]
20. Sequential analysis of latent variables using mixed-effect latent variable models: Impact of non-informative and informative missing data.
Sébille V; Hardouin JB; Mesbah M
Stat Med; 2007 Nov; 26(27):4889-904. PubMed ID: 17576119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
